Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)

General Information of Drug (ID: DR1762)
Drug Name
Deferiprone
Synonyms
Deferiprone (INN); Ferriprox; deferiprone; 1,2-Dimethyl-3-hydroxy-4(1H)-pyridinone; 1,2-Dimethyl-3-hydroxypyrid-4-one; APO-066; APO-66; DN-180-01-AF; 1,2-Dimethyl-3-hydroxypyridine-4-one; 1,2-dimethyl-3-hydroxy-4-pyridone; 2BTY8KH53L; 3-Hydroxy-1,2-dimethyl-4(1H)-pyridone; 3-hydroxy-1,2-dimethylpyridin-4(1H)-one; 3-hydroxy-1,2-dimethylpyridin-4-one; 30652-11-0; 4(1H)-Pyridinone, 3-hydroxy-1,2-dimethyl-; BRN 1447108; CP20; CP20 (Chelating agent); HK-1; L1; MFCD00134497; MLS000069481; UNII-2BTY8KH53L
Indication Thalassaemia [ICD11: 3A50] Approved [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 139.15 Topological Polar Surface Area 40.5
Heavy Atom Count 10 Rotatable Bond Count 0
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 3
Cross-matching ID
PubChem CID
2972
PubChem SID
619486 ; 3141081 ; 5185332 ; 8139956 ; 8151894 ; 12014095 ; 12016210 ; 15120034 ; 24863630 ; 26719648 ; 26752603 ; 29222122 ; 46386865 ; 50033992 ; 50511870 ; 51091751 ; 53787887 ; 57288765 ; 57321538 ; 87571300 ; 88835489 ; 92308275 ; 99452950 ; 103267492 ; 104233432 ; 104302153 ; 114916997 ; 117477666 ; 118274575 ; 121362354 ; 124594983 ; 124658784 ; 124800098 ; 125504819 ; 126604544 ; 129338095 ; 134999734 ; 137034119 ; 142312282 ; 143396714 ; 144075741 ; 144097800 ; 144205982 ; 152041705 ; 160645804 ; 160794436 ; 162022029 ; 162138833 ; 162221207 ; 162290948
ChEBI ID
ChEBI:68554
CAS Number
30652-11-0
TTD Drug ID
D0N0OU
Formula
C7H9NO2
Canonical SMILES
CC1=C(C(=O)C=CN1C)O
InChI
1S/C7H9NO2/c1-5-7(10)6(9)3-4-8(5)2/h3-4,10H,1-2H3
InChIKey
TZXKOCQBRNJULO-UHFFFAOYSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
Deferiprone 3-o glucuronide metabolite DM001954
10064278
Unclear 1 [3]
Deferiprone metabolite M1 DM001950
323814
Unclear 1 [2]
Deferiprone metabolite M4 DM001951
71302992
Unclear 2 [2]
Deferiprone metabolite M2 DM001952 N. A. Unclear 3 [2]
Deferiprone metabolite M3 DM001953 N. A. Unclear 3 [2]
Deferiprone metabolite M3 DM001953 N. A. Unclear 4 [2]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR002939 Deferiprone Deferiprone metabolite M1 Unclear CYP2A6 [2]
MR002940 Deferiprone Deferiprone 3-o glucuronide metabolite Unclear UGT1A6 [3]
MR002935 Deferiprone metabolite M1 Deferiprone metabolite M4 Unclear CYP2A6 [2]
MR002936 Deferiprone metabolite M4 Deferiprone metabolite M2 Unclear Unclear [2]
MR002937 Deferiprone metabolite M4 Deferiprone metabolite M3 Unclear Unclear [2]
MR002938 Deferiprone metabolite M2 Deferiprone metabolite M3 Unclear Unclear [2]
⏷ Show the Full List of 6 MR(s)
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Cytochrome P450 2A6 (CYP2A6) DME0005 Homo sapiens
CP2A6_HUMAN
1.14.14.1
[2]
UDP-glucuronosyltransferase 1A6 (UGT1A6) DME0072 Homo sapiens
UD16_HUMAN
2.4.1.17
[3]
References
1 Deferiprone was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration.
2 Metabolic activation of deferiprone mediated by CYP2A6 Xenobiotica. 2021 Nov;51(11):1282-1291. doi: 10.1080/00498254.2021.1931729.
3 Deferiprone glucuronidation by human tissues and recombinant UDP glucuronosyltransferase 1A6: an in vitro investigation of genetic and splice variants. Drug Metab Dispos. 2009 Feb;37(2):322-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.